Details for Patent: 11,903,955
✉ Email this page to a colleague
Which drugs does patent 11,903,955 protect, and when does it expire?
Patent 11,903,955 protects FARXIGA and is included in one NDA.
This patent has twenty-eight patent family members in nineteen countries.
Drugs Protected by US Patent 11,903,955
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca Ab | FARXIGA | dapagliflozin | TABLET;ORAL | 202293-002 | Jan 8, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | REDUCE THE RISK OF CARDIOVASCULAR DEATH AND WORSENING HEART FAILURE IN ADULTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION, WITHOUT TYPE II DIABETES, AND HAVING AN HBA1C OF < 5.7% | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,903,955
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 118963 | ⤷ Try a Trial | |||
| Australia | 2020202887 | ⤷ Try a Trial | |||
| Australia | 2021215150 | ⤷ Try a Trial | |||
| Australia | 2023210548 | ⤷ Try a Trial | |||
| Brazil | 112020008705 | ⤷ Try a Trial | |||
| Canada | 3079175 | ⤷ Try a Trial | |||
| Chile | 2020001335 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
